FIORICET W/ CODEINE Drug Patent Profile
✉ Email this page to a colleague
When do Fioricet W/ Codeine patents expire, and when can generic versions of Fioricet W/ Codeine launch?
Fioricet W/ Codeine is a drug marketed by Actavis Labs Ut Inc and is included in one NDA.
The generic ingredient in FIORICET W/ CODEINE is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
Summary for FIORICET W/ CODEINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FIORICET W/ CODEINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FIORICET W/ CODEINE
US Patents and Regulatory Information for FIORICET W/ CODEINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | FIORICET W/ CODEINE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 020232-001 | Jul 30, 1992 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |